UNSPSC 51281701: Lenampicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H23N3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8M568DM08K, chemically known as 2,3-dihydroxy-2-butenyl(2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, cyclic carbonate but generally known as lenampicillin, which bears US NIH Compound Identifier 65646.

UNSPSC 51281701 Lenampicillin is a Commodity code that nominally covers a specific antibiotic product, but the recent state and local solicitations tagged under this code do not reflect purchases of lenampicillin itself. Instead, the opportunities posted under this code show activity in emergency medical supplies, naloxone and drug deactivation systems, generic pharmaceuticals and OTC products, and prescription program infrastructure — a significant scope mismatch that suggests either misclassification at posting or a data tagging error. The state and local buyers active under this code span county health departments, municipal fire and rescue divisions, state health and human services agencies, and cooperative purchasing alliances serving multi-state networks. Seminole County, Florida; the City of Tampa; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the issuing bodies in recent opportunities. The work being solicited ranges from procurement of emergency naloxone and drug deactivation systems through competitive sealed bids to the establishment of multi-award contracts for generic pharmaceuticals and OTC products distributed through authorized wholesalers and to the exploration of direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager channels.

Recent opportunities reflect activity across Florida, Texas, Minnesota, and Oregon. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building (response due July 26, 2023); the City of Tampa's sealed bid for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000 and designated as a sheltered market opportunity exclusively for certified Small Local Business Enterprises with a 5% bid discount not to exceed $10,000 (response due March 13, 2026); MMCAP's RFP to establish multiple contracts for generic multi-source pharmaceuticals and OTC products effective July 1, 2026 (proposal due March 26, 2026); and the Texas Health and Human Services Commission's RFI soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program (response due April 3, 2026). The code shows little relevant recent activity aligned to its nominal scope; prospective bidders should verify that opportunities posted under this code match their actual product or service line before investing in proposal development.